Ginkgomax®
(Ginkgo biloba leaf extract capsules)

Description

Usage

 Dosage

1 capsule/time
twice daily

Package

50 capsules /18 g
120 capsules/44 g

Ginkgomax® (ethanol extract) is also available.

References

  1. Ritch R.  
    Complementary therapy for the treatment of glaucoma: a perspective.
    Ophthalmol Clin North Am. 2005 Dec;18(4):597-609. Review.
  2. Ginkgo biloba special extract EGb 761 in the treatment of peripheral arterial occlusive disease (PAOD)--a review based on randomized, controlled studies.
    Horsch S, Walther C.
    Int J Clin Pharmacol Ther. 2004 Feb;42(2):63-72.
  3. Review about Ginkgo biloba special extract EGb 761 (Ginkgo).
    Gertz HJ, Kiefer M.
    Curr Pharm Des. 2004;10(3):261-4.
  4. Effects of Ginkgo biloba on mental functioning in healthy volunteers.
    Cieza A, Maier P, Poppel E.             
    Arch Med Res. 2003 Sep-Oct;34(5):373-81.
  5. Value of Ginkgo biloba in treatment of Alzheimer dementia
    Loew D.
    Wien Med Wochenschr 2002;152(15-16):418-22
  6. The CNS effects of Ginkgo biloba extracts and ginkgolide B.
    Maclennan KM, Darlington CL, Smith PF.
    Prog Neurobiol 2002 Jun;67(3):235-57
  7. Influence of the severity of cognitive impairment on the effect of the Gnkgo biloba extract EGb 761 in Alzheimer's disease.
    Le Bars PL, Velasco FM, Ferguson JM, Dessain EC, Kieser M, Hoerr R.
    Neuropsychobiology 2002;45(1):19-26
  8. Protective effects of a Ginkgo biloba extract (EGb 761) on ischemia-reperfusion injury
    Clostre F.
    Therapie 2001 Sep-Oct;56(5):595-600
  9. Efficacy, safety, and use of ginkgo biloba in clinical and preclinical applications.
    McKenna DJ, Jones K, Hughes K.
    Altern Ther Health Med 2001 Sep-Oct;7(5):70-86, 88-90
  10. Ginkgo special extract EGb 761 in tinnitus therapy. An overview of results of completed clinical trials.
    Holstein N.
    Fortschr Med 2001 Jan 11;118(4):157-64
  11. Ginkgo biloba extract: mechanisms and clinical indications.
    Diamond BJ, Shiflett SC, Feiwel N, Matheis RJ, Noskin O, Richards JA, Schoenberger NE
    Arch Phys Med Rehabil 2000 May;81(5):668-78
  12. Identification of kaempferol as a monoamine oxidase inhibitor and potential Neuroprotectant in extracts of Ginkgo biloba leaves.
    Sloley BD, Urichuk LJ, Morley P, Durkin J, Shan JJ, Pang PK, Coutts RT
    J Pharm Pharmacol 2000 Apr;52(4):451-9
  13. Therapeutic value of Ginkgo biloba in reducing symptoms of decline in mental function.
    Curtis-Prior P, Vere D, Fray P
    J Pharm Pharmacol 1999 May 51:5 535-41
  14. [Ginkgo biloba extract (EGb 761). State of knowledge in the dawn of the year 2000]
    Clostre F
    Ann Pharm Fr 1999 Jul 57 Suppl 1 1S8-88
  15. S. Kanowski et al.
    Proof of efficiency of the Ginkgo biloba special extract EGb761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia
    Pharmacopsychiatry 29, 47-56 (1996)
  16. Cohen AJ, Bartlik B
    Ginkgo biloba for antidepressant-induced sexual dysfunction.
    J Sex Marital Ther 1998 Apr-Jun 24:2 139-43
  17. B. Steinke et al.
    Biological standardization of Ginkgo extract
    Planta. Med. 59, 155-160 (1993)
  18. J. Klein et al.
    Phospholipid breakdown and choline release under hypoxic conditions: inhibition by bilobalide, a constituent of Ginkgo biloba
    Brain Res. 755, 347-350 (1997)
  19. Potential role for Ginkgo biloba extract in the treatment of glaucoma.
    Ritch R
    Med Hypotheses 2000 Feb;54(2):221-35

(References searched and cited from National Library of Medicine-PubMed at http://www.ncbi.nlm.nih.gov/PubMed/ )

 This site edited and maintained by Yu Heci

The information provided on this site is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.

Updated August 17, 2006

Copyright © 1998-2006

Hankintatukku Natural Health Products Co.


Museokatu 13 B, FIN-00100, Helsinki, FINLAND


Home | e-mail | Top | Product List | Contact|